Roche (OTCMKTS:RHHBY) Reaches New 52-Week High – Still a Buy?

Roche Holding AG (OTCMKTS:RHHBY)’s share price reached a new 52-week high on Monday . The stock traded as high as $43.96 and last traded at $43.06, with a volume of 4303336 shares traded. The stock had previously closed at $43.89.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the company. Sanford C. Bernstein raised Roche to a “strong-buy” rating in a research note on Thursday, January 30th. UBS Group upgraded Roche from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 13th. Finally, Morgan Stanley initiated coverage on shares of Roche in a research note on Wednesday, February 12th. They issued an “equal weight” rating for the company. Two equities research analysts have rated the stock with a sell rating, one has assigned a hold rating, one has given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy”.

Roche Trading Up 3.7 %

The stock’s 50 day moving average price is $39.31 and its two-hundred day moving average price is $38.48. The company has a quick ratio of 0.97, a current ratio of 1.26 and a debt-to-equity ratio of 0.86.

Institutional Investors Weigh In On Roche

Several institutional investors have recently added to or reduced their stakes in the business. Altrius Capital Management Inc increased its stake in Roche by 0.3% in the 4th quarter. Altrius Capital Management Inc now owns 183,448 shares of the company’s stock valued at $6,399,000 after buying an additional 603 shares during the period. Bard Financial Services Inc. grew its holdings in Roche by 37.7% in the fourth quarter. Bard Financial Services Inc. now owns 110,850 shares of the company’s stock valued at $3,866,000 after purchasing an additional 30,350 shares during the last quarter. Diversified Trust Co raised its position in shares of Roche by 1.2% during the 4th quarter. Diversified Trust Co now owns 60,453 shares of the company’s stock worth $2,130,000 after purchasing an additional 711 shares during the last quarter. Hantz Financial Services Inc. increased its position in Roche by 0.9% during the 4th quarter. Hantz Financial Services Inc. now owns 33,708 shares of the company’s stock worth $1,176,000 after purchasing an additional 305 shares in the last quarter. Finally, Hancock Whitney Corp increased its stake in Roche by 6.8% in the fourth quarter. Hancock Whitney Corp now owns 23,516 shares of the company’s stock valued at $820,000 after purchasing an additional 1,496 shares during the last quarter.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.